A few screen shots from the Amgen data sheet of Carfilzomib....
Seems to be some really strong drivers for Amgen to move an investigator led trial on the combination given the patent cliff and the carditoxicity of this drug on patients!
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-29
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
0.000(0.00%) |
Mkt cap ! $247.0M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.41 | $77.22K | 54.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1814 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 1300 | 1 |
View Market Depth
| Last trade - 12.26pm 07/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |